The Board of Directors of Sansure Biotech Inc. has authorized a buyback plan on October 20, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.94 CNY | -0.20% | -3.67% | +1.99% |
26/04 | Sansure Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
29/02 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.99% | 1.59B | |
-4.57% | 12.32B | |
-4.35% | 8.1B | |
+8.91% | 5.87B | |
+30.59% | 5.52B | |
-7.42% | 4.29B | |
-54.20% | 3.16B | |
+14.44% | 2.72B | |
-2.21% | 2.37B | |
+29.00% | 2.23B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Sansure Biotech Inc. authorizes a Buyback Plan.